| Our
Services
GfK U.S. Healthcare Companies –
The leaders in pharmaceutical marketing consulting and marketing research
services.
No matter what type of project you have – global or domestic, qualitative
or quantitative, high-end consultation or simple data collection, or the
need for a custom or syndicated study – the GfK U.S. Healthcare Companies
has a way to best meet your research needs.
Our three distinct, premium brands – GfK Market Measures, GfK Strategic
Marketing, and GfK V2 – each has specific expertise in different areas
of healthcare marketing and marketing research, therefore offering you the
opportunity to work with the right company and the right team to get the
right results for your individual project.
Staffed by only the “best of the best” in the industry, GfK
Market Measures, GfK Strategic Marketing and GfK V2’s highly skilled
marketing and marketing research consultants have been breaking boundaries
to create the innovative methodologies, unique products, and “out-of-the-box”
marketing approaches that give you the edge in today’s hyper-competitive
healthcare environment. A sampling of these products and services include:
- CAST™ (Competitive Analysis of Strategy and Tactics)
– a unique, more consultative, approach to “war gaming”
in marketing research
- Concept Evaluation Studies – gather
feedback on clarity, persuasiveness, credibility and relevance of messages
- ConcepTest.Com™ – A Web-based
concept evaluation tool that gives you fast insight into how provides
and patients will react to new brands, line extensions, added indications
of product enhancements
- Creative Coalitions
- an iterative research technique that uses respondents as creative
partners in message development
- Detail Tracker™ – a new continuous
tracking tool for trending, evaluating and optimizing sales force effectiveness
- Detail Watch™ – through a totally
Web-based process that delivers results in real time, you get a custom
view of physician-rep interactions
- Diabetes Patient Market Study™ –
Providing a global perspective on diabetes by delivering comparable
results in major regions around the world, including the US, Europe,
Latin America and the Far East
- Fastape Premium™ – through
Interactive Voice Response (IVR) interviewing, Fastape Plus delivers
direct-from-physician insights on the believability and credibility
of messages, as well as the impact of presentations on prescribing
- Information Architecture™ –
a rigorous, multifaceted approach to product positioning and message
development
- Issues-Based Studies – several new
studies examine the impact of Medicare Part D including: The Impact
of MMA on Managed Care Organizations, The Impact of MMA on Physicians
and The Impact of MMA on Patients
- KOL (Knowledge Opinion Leader) Research
– qualitative exploration to understand trends and 'bleeding edge'
practices and attitudes
- MAPPs™ (Market Analysis of Patients and Products)
– a proprietary approach to patient/treatment maps
- Market Segmentation Studies – an
innovative approach employing a variety of techniques such as Latent
Class Segmentation and CART to identify key market groups for targeting
- Opinion Leader Colloquia - specialized
seminars that guide R&D and marketing departments in developing
new products, as well as long-range strategic plans and programs
- Outcomes and Comparators Studies –
provide insights into the relative impact of alternative clinical trial
designs on intended prescribing
- PatientDriver™ Studies – by
profiling and segmenting key patient groups, PatientDriver Studies guide
you in choosing the media and messages that motivate target audiences
- Patient Records and Experience Studies
– provide insights into patients’ preferences and problems
with therapies
- Perceptual Deficit Simulator
– a diagnostic tool for assessing the impact of poor awareness
or misconceptions about marketed products (your own or competitor's)
and for directing promotional focus to product features that will impact
share
- PracticeView™ – an innovative
“account management” approach which shows product managers
how to gain a competitive advantage by marketing to physicians at the
group practice level
- Qualitative Segmentation Refinement –
in-depth qualitative exploration and understanding the 'whats' and the
'whys' within relevant market segments
- ROI on Direct-to-Consumer Advertising and Tracking Studies
– measure the bottom-line effectiveness of “pull-through”
advertising strategies
- Strategic Bundle Analysis - a unique methodology,
revealing the messages that work best together to drive prescribing
- Strategic Choice Modeling - a proprietary
discrete choice model for identifying the optimum pricing, positioning,
forecasts and penetration strategies
- The Patient Speaks
- a cross-observational methodology that uncovers divergent perspectives,
and explores brand use, compliance and other issues within the context
of the patient/physician dynamic
- Therapeutic Class Studies – offering
detailed market analyses across 40+ categories, providing critical insights,
straight from top-prescribing physicians
- Uniter
and Hospital Uniter
- links managed care and/or patient perspectives to build more realistic
forecasts, or for hospital products, to reflect the sometimes divergent
views of pharmacists and physicians
To learn more about the GfK U.S. Healthcare Companies’ brands and
how our people, products and services can best meet your business needs,
please contact:
Barry Zimmerman, President
800.456.4405, x3980 or bzimmerman@gfkmarketmeasures.com
www.gfkmarketmeasures.com
Brian Hull, President
610.667.1649 or bhull@gfksm.com
www.gfksm.com
Bart Weiner, President
215.283.3200 x363 or bweiner@gfkv2.com
www.gfkv2.com
|
